Sign In
The Journey Medical Corporation stock price gained 1.75% on the last trading day (Tuesday, 24th Feb 2026), rising from $8.55 to $8.70. It has now gained 7 days in a row. It is not often that stock manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the stock fluctuated 6.22% from a day low at $8.52 to a day high of $9.05. The price has risen in 8 of the last 10 days and is up by 8.21% over the past 2 weeks. Volume fell on the last day by -4 thousand shares and in total, 83 thousand shares were bought and sold for approximately $723.93 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
On Aug 25, 2025, it was reported that H.C. Wainwright gave DERM a "Buy" grade with a "initialise" action.
The stock lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled.Given the current short-term trend, the stock is expected to rise 8.86% during the next 3 months and, with a 90% probability hold a price between $8.49 and $10.39 at the end of this 3-month period.
The Journey Medical Corporation stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $8.35 and $8.20. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, February 12, 2026, and so far it has risen 12.84%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.
On the downside, the stock finds support just below today's level from accumulated volume at $8.04 and $7.92.There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Journey Medical Corporation finds support just below today's level at $8.04. If this is broken, then the next support from accumulated volume will be at $7.92 and $7.87.
This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.530 between high and low, or 6.22%. For the last week the stock has had daily average volatility of 4.49%.
Since the Journey Medical Corporation has been rising for 7 days in a row, the risk over the next couple of days has increased. We don't expect a major reaction as the stock is in very good shape technically, and therefore hold a positive evaluation despite the very short term risk.
Journey Medical Corporation holds several positive signals and is within a weak rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.
Check full Journey Medical Corporation forecast and analysis here.